Hepatite relacionada a drogas antituberculose: perfil de 149 pacientes internados no Hospital Universitario Joao de Barros Barreto no periodo de janeiro de 1984 a dezembro de 1990

Cardoso, Ninarosa Calzavara.
s.l; Hospital Universitario Joao de Barros Barreto; 1990. [17] p. tab.
Não convencional em Português | LILACS | ID: lil-119192

Documentos relacionados

  1. Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
  2. Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study.
  3. Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.
  4. Treatment of latent tuberculosis infection: a network meta-analysis.
  5. Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
  6. Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment Outcomes.
  7. Treatment Strategy for Rifampin-Susceptible Tuberculosis.
  8. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
  9. Predictive Modeling to Study the Treatment-Shortening Potential of Novel Tuberculosis Drug Regimens, Toward Bundling of Preclinical Data.
  10. Tuberculosis: Common Questions and Answers.